Alzheimer's disease classification using hybrid Alex-ResNet-50 model Online publication date: Fri, 08-Nov-2024
by E. Semmalar; R. Shobarani
International Journal of Bioinformatics Research and Applications (IJBRA), Vol. 20, No. 6, 2024
Abstract: Alzheimer's disease (AD), a leading cause of dementia and mortality, presents a growing concern due to its irreversible progression and the rising costs of care. Early detection is crucial for managing AD, which begins with memory deterioration caused by the damage to neurons involved in cognitive functions. Although incurable, treatments can manage its symptoms. This study introduces a hybrid AlexNet+ResNet-50 model for AD diagnosis, utilising a pre-trained convolutional neural network (CNN) through transfer learning to analyse MRI scans. This method classifies MRI images into Alzheimer's disease (AD), moderate cognitive impairment (MCI), and normal control (NC), enhancing model efficiency without starting from scratch. Incorporating transfer learning allows for refining the CNN to categorise these conditions accurately. Our previous work also explored atlas-based segmentation combined with a U-Net model for segmentation, further supporting our findings. The hybrid model demonstrates superior performance, achieving 94.21% accuracy in identifying AD cases, indicating its potential as a highly effective tool for early AD diagnosis and contributing to efforts in managing the disease's impact.
Existing subscribers:
Go to Inderscience Online Journals to access the Full Text of this article.
If you are not a subscriber and you just want to read the full contents of this article, buy online access here.Complimentary Subscribers, Editors or Members of the Editorial Board of the International Journal of Bioinformatics Research and Applications (IJBRA):
Login with your Inderscience username and password:
Want to subscribe?
A subscription gives you complete access to all articles in the current issue, as well as to all articles in the previous three years (where applicable). See our Orders page to subscribe.
If you still need assistance, please email subs@inderscience.com